June 2015 FDA Recall Drug by Qualitest Pharmaceuticals
D-1239-2015 - Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable

This Class III drug recall was voluntarily initiated by Qualitest Pharmaceuticals on June 29, 2015 for the product Drug. The FDA reported the reason for recall as failed tablet/capsule specifications; the identification codes on some tablets may be unreadable. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1239-2015

Reason for Recall
Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable
Initiated
06-29-2015
Reported
07-22-2015
Quantity
47,376 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Qualitest Pharmaceuticals
HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (NDC 0603-3968-28) and 1000 count (NDC 0603-3968-32) bottles, Manufactured for Qualitest Pharmaceuticals, Huntsville, AL

Batch or Lot Expiration Information

Lot# 100 count (NDC 0603-3968-21); LOTS# T144F13A, T130G13B, T132G13A, exp date 6/15, T115D14A, exp date 3/16; 500 count (NDC 0603-3968-28)
Lot# T144F13B exp date 6/15; and 1000 count (NDC 0603-3968-32); LOTS # T144F13C, T132G13B, exp date 6/15, T115D14B, exp date 3/16